Pfizer Seeks Approval For Covid Jabs For Children Aged 5-11 In Canada
NDTV
Coronavirus Vaccine: Pfizer's authorization request is based on data from trials conducted on 2,268 children in the age group.
Pfizer-BioNTech submitted an authorization request to Health Canada on Monday for the use of its Covid-19 vaccine in children aged 5-11, the companies and the Canadian government said.
"This is the first submission Health Canada has received for the use of a Covid-19 vaccine in this younger age group," it said in a statement.
The authorization request is based on data from trials conducted on 2,268 children in this age group for whom the dosage was lowered to 10 micrograms per injection -- three times less than the standard dose -- which the company says is "the preferred dose" for 5-11 year olds.
This same Pfizer-BioNTech vaccine is approved in Canada for ages 12 and up.
